These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 6397984)

  • 81. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques.
    Nilsson T; Longmore J; Shaw D; Pantev E; Bard JA; Branchek T; Edvinsson L
    Eur J Pharmacol; 1999 May; 372(1):49-56. PubMed ID: 10374714
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin.
    Cocks TM; Angus JA
    Nature; 1983 Oct 13-19; 305(5935):627-30. PubMed ID: 6621711
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Antiserotonergic properties of terguride in blood vessels, platelets, and valvular interstitial cells.
    Kekewska A; Görnemann T; Jantschak F; Glusa E; Pertz HH
    J Pharmacol Exp Ther; 2012 Feb; 340(2):369-76. PubMed ID: 22049464
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effect of 5-HT2-selective agonists on cat platelet aggregation.
    Seggel MR; Qureshi GD; Glennon RA
    Life Sci; 1987 Aug; 41(9):1077-81. PubMed ID: 3613863
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries.
    Golino P; Buja LM; Ashton JH; Kulkarni P; Taylor A; Willerson JT
    Circulation; 1988 Sep; 78(3):701-11. PubMed ID: 3409505
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
    Cushing DJ; Cohen ML
    J Pharmacol Exp Ther; 1993 Jan; 264(1):193-200. PubMed ID: 8423526
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Leukocyte and platelet-derived factors augment canine coronary constriction to serotonin.
    Cappelli-Bigazzi M; Lamping KG; Nuno DW; Harrison DG
    Am J Physiol; 1990 Oct; 259(4 Pt 2):H1161-70. PubMed ID: 2171364
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Characterization of the 5-HT receptor mediating endothelium-dependent relaxation in porcine vena cava.
    Sumner MJ
    Br J Pharmacol; 1991 Apr; 102(4):938-42. PubMed ID: 1855122
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Endothelial cells and the electrical and mechanical responses of the rabbit coronary artery to 5-hydroxytryptamine.
    Garland CJ
    J Pharmacol Exp Ther; 1985 Apr; 233(1):158-62. PubMed ID: 3981453
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Effect of the thromboxane A2-mimetic U46619 on 5-HT1-like and 5-HT2 receptor-mediated contraction of the rabbit isolated femoral artery.
    MacLennan SJ; Martin GR
    Br J Pharmacol; 1992 Oct; 107(2):418-21. PubMed ID: 1422590
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors.
    Kaumann AJ; Frenken M; Posival H; Brown AM
    Circulation; 1994 Sep; 90(3):1141-53. PubMed ID: 8087924
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The role of serotonin in thrombogenesis.
    De Clerck F
    Clin Physiol Biochem; 1990; 8 Suppl 3():40-9. PubMed ID: 1966729
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Serotonin and preactivated platelets in essential hypertension.
    Bühler FR; Amstein R; Fetkovska N
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S32-4. PubMed ID: 2446066
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Rabbit isolated renal artery contractions by some tryptamine derivatives, including 2-methyl-5-HT, are mediated by a 5-HT1-like receptor.
    Tadipatri S; Feniuk W; Saxena PR
    Br J Pharmacol; 1992 Oct; 107(2):322-8. PubMed ID: 1422584
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Therapeutic benefits of 5-hydroxytryptamine inhibition following pulmonary embolism.
    Huval WV; Mathieson MA; Stemp LI; Dunham BM; Jones AG; Shepro D; Hechtman HB
    Ann Surg; 1983 Feb; 197(2):220-5. PubMed ID: 6824376
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Vascular 5-HT1-like receptors mediating vasoconstriction and vasodilatation: their characterization and distribution in the intact canine cardiovascular system.
    Cambridge D; Whiting MV; Butterfield LJ; Marston C
    Br J Pharmacol; 1995 Mar; 114(5):961-8. PubMed ID: 7780651
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Effects of monoamines formed in the cecum of horses on equine digital blood vessels and platelets.
    Elliott J; Berhane Y; Bailey SR
    Am J Vet Res; 2003 Sep; 64(9):1124-31. PubMed ID: 13677390
    [TBL] [Abstract][Full Text] [Related]  

  • 98. 5-HT decreases contractile and electrical activities in lymphatic vessels of the guinea-pig mesentery: role of 5-HT 7-receptors.
    Chan AK; von der Weid PY
    Br J Pharmacol; 2003 May; 139(2):243-54. PubMed ID: 12770929
    [TBL] [Abstract][Full Text] [Related]  

  • 99. LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays occlusion in a rabbit model of thrombosis.
    Cohen ML; Robertson DW; Bloomquist WE; Wilson HC
    J Pharmacol Exp Ther; 1992 Apr; 261(1):202-8. PubMed ID: 1560366
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Dynamics of platelet mobilisation into lungs in response to 5-hydroxytryptamine (serotonin) in mice.
    Yu Z; Ohba M; Nakamura M; Sasano T; Ono M; Sugawara S; Endo Y
    Thromb Haemost; 2009 Dec; 102(6):1251-8. PubMed ID: 19967158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.